Prevalence of arterial hypertension in the population of Western Germany. Heinz Nixdorf Recall Study;Prävalenz der arteriellen Hypertonie in der westdeutschen Bevölkerung. Heinz Nixdorf Recall Studie

Herz

Volumn 37, Issue 7, 2012, Pages 721-727

  Horacek, M ^a   Mohlenkamp S ^b   Mahabadi, A A ^a   Churzidse, S ^a   Moebus, S ^c   Jockel K H ^c   Erbel, R ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Krankenhaus Bethanien   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Coronary atherosclerosis; Heinz Nixdorf Recall Study; Hypertension; Prevalence; Risk stratification

Indexed keywords

AGE; ARTICLE; ATHEROSCLEROSIS; AWARENESS; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISEASE; FOLLOW UP; GERMANY; HUMAN; HYPERTENSION; POPULATION RESEARCH; PREHYPERTENSION; PREVALENCE; PRIMARY PREVENTION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SCREENING TEST; SECONDARY PREVENTION;

AGED; COMORBIDITY; CORONARY ARTERY DISEASE; FEMALE; GERMANY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION;

EID: 84872268156     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-012-3684-z     Document Type: Article

References (40)

1. Assmann G, Schulte H, Cullen P (1997) New and classical risk factors - the Munster heart study (PROCAM). Eur J Med Res 2(6):237-242
2. Kannel WB (1990) CHD risk factors: a Framingham study update. Hosp Pract (Off Ed) 25(7):119-127, 130
3. Keil U, Liese AD, Hense HW et al (1998) Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-1992. Monitoring trends and determinants in cardiovascular diseases. Eur Heart J 19(8):1197-1207
4. Perk J, De Backer G, Gohlke H et al (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Atherosclerosis 223(1):1-68
5. World Health Organisation (2005) The European Health Report 2005: public health action for healthier children and populations. Statistical tables. World Health Organisation, Copenhagen
6. Chalmers J, MacMahon S, Mancia G et al (1999) 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens 21(5-6):1009-1060
7. Chobanian AV, Bakris GL, Black HR et al (2003) The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289(19):2560-2572
8. Mancia G, De BG, Dominiczak A et al (2007) 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28(12):1462-1536
9. Erbel R, Lehmann N, Mohlenkamp S et al (2012) Subclinical coronary atherosclerosis predicts cardiovascular risk in different stages of hypertension: result of the Heinz Nixdorf Recall Study. Hypertension 59(1):44-53
10. Schmermund A, Mohlenkamp S, Stang A et al (2002) Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk factors, evaluation of coronary calcium and lifestyle. Am Heart J 144(2):212-218
11. Stang A, Moebus S, Dragano N et al (2005) Baseline recruitment and analyses of nonresponse of the Heinz Nixdorf Recall Study: identifiability of phone numbers as the major determinant of response. Eur J Epidemiol 20(6):489-496
12. Erbel R, Eisele L, Moebus S et al (2012) The Heinz Nixdorf Recall Study. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55(6-7):809-815
13. Stang A, Moebus S, Mohlenkamp S et al (2006) Algorithms for converting random-zero to automated oscillometric blood pressure values, and vice versa. Am J Epidemiol 164(1):85-94
14. Garrow JS (1963) Zero-muddler for unprejudiced sphygmomanometry. Lancet 2(7319):1205
15. Kuulasmaa K, Tunstall-Pedoe H, Dobson A et al (2000) Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 355(9205):675-687
16. Vargas CM, Ingram DD, Gillum RF (2000) Incidence of hypertension and educational attainment: the NHANES I epidemiologic followup study. First National Health and Nutrition Examination Survey. Am J Epidemiol 152(3):272-278
17. Wilsgaard T, Jacobsen BK, Schirmer H et al (2001) Tracking of cardiovascular risk factors: the Tromso study, 1979-1995. Am J Epidemiol 154(5):418-426
18. Hofman A, Grobbee DE, Jong PT de et al (1991) Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 7(4):403-422
19. Vasan RS, Larson MG, Leip EP et al (2001) Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 345(18):1291-1297
20. Conroy RM, O'Brien E, O'Malley K et al (1993) Measurement error in the Hawksley random zero sphygmomanometer: what damage has been done and what can we learn? BMJ 306(6888):1319-1322
21. Evans JG, Prior IA (1970) Experience with the random-zero sphygmomanometer. Br J Prev Soc Med 24(1):10-15
22. Lawson M, Johnston A (1993) The Hawksley random zero sphygmomanometer. Should be abandoned. BMJ 307(6896):123
23. McGurk C, Nugent A, McAuley D et al (1997) Sources of inaccuracy in the use of the Hawksley random-zero sphygmomanometer. J Hypertens 15(12 Pt 1):1379-1384
24. O'Brien E, Mee F, Atkins N et al (1990) Inaccuracy of the Hawksley random zero sphygmomanometer. Lancet 336(8729):1465-1468
25. O'Brien E, Waeber B, Parati G et al (2001) Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ 322(7285):531-536
26. Mackie A, Whincup P, McKinnon M (1995) Does the Hawksley random zero sphygmomanometer underestimate blood pressure, and by how much? J Hum Hypertens 9(5):337-343
27. Erbel R, Mohlenkamp S, Jockel KH et al (2008) Cardiovascular risk factors and signs of subclinical atherosclerosis in the Heinz Nixdorf Recall Study. Dtsch Arztebl Int 105(1-2):1-8
28. Churzidse S (2008) Abhängigkeit der subklinischen Atherosklerose der Koronargefäße von der Höhe des Blutdruckes und Cholesterinspiegels. Die Ergebnisse der Heinz Nixdorf Recall Studie [Dissertation], Medizinische Fakultät der Universität Duisburg-Essen, Westdeutsches Herzzentrum Essen, Klinik für Kardiologie
29. Stang A, Moebus S, Möhlenkamp S et al (2004) Prevalence and determinants of arterial hypertension in the Ruhrarea: Results of the Heinz Nixdorf Recall Study. Meeting Abstract, 49. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (gmds)
30. Erbel R, Mohlenkamp S, Moebus S et al (2010) Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol 56(17):1397-1406
31. Meisinger C, Heier M, Volzke H et al (2006) Regional disparities of hypertension prevalence and management within Germany. J Hypertens 24(2):293-299
32. Thamm M (1999) Blood pressure in Germany - current status and trends. Gesundheitswesen 61 Spec No:90-93
33. Lowel H, Meisinger C, Heier M et al (2006) Epidemiology of hypertension in Germany. Selected results of population-representative cross-sectional studies. Dtsch Med Wochenschr 131(46):2586-2591
34. Gasse C, Hense HW, Stieber J et al (2001) Assessing hypertension management in the community: trends of prevalence, detection, treatment, and control of hypertension in the MONICA Project, Augsburg 1984-1995. J Hum Hypertens 15(1):27-36
35. Evans A, Tolonen H, Hense HW et al (2001) Trends in coronary risk factors in the WHO MONICA project. Int J Epidemiol 30(Suppl 1):35-40
36. Volzke H (2012) Study of Health in Pomerania (SHIP): concept, design and selected results. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55(6-7):790-794
37. Wolf-Maier K, Cooper RS, Banegas JR et al (2003) Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289(18):2363-2369
38. Erbel R, Delaney JA, Lehmann N et al (2008) Signs of subclinical coronary atherosclerosis in relation to risk factor distribution in the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall Study (HNR). Eur Heart J 29(22):2782-2791
39. Bild DE, Bluemke DA, Burke GL et al (2002) Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156(9):871-881
40. Prugger C, Heidrich J, Wellmann J et al (2012) Trends in cardiovascular risk factors among patients with coronary heart disease: results from the EUROASPIRE I, II, and III surveys in the Munster region. Dtsch Arztebl Int 109(17):303-310